SIRS
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Baxter InternationalDEERFIELD, IL
1 programEffects of IV Chloride Content on OutcomesN/A1 trial
Active Trials
Mochida PharmaceuticalJapan - Tokyo
1 programUtility of Presepsin in Distinguishing Between Sepsis and SIRSN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Mochida PharmaceuticalUtility of Presepsin in Distinguishing Between Sepsis and SIRS
Baxter InternationalEffects of IV Chloride Content on Outcomes
Clinical Trials (2)
Total enrollment: 1,784 patients across 2 trials
Utility of Presepsin in Distinguishing Between Sepsis and SIRS
Start: Jan 2014Est. completion: Jul 2015226 patients
N/ACompleted
Effects of IV Chloride Content on Outcomes
Start: Sep 2013Est. completion: Apr 20141,558 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.